Skip to main content
SpringerLink
Log in

Carcinoma of the prostate: Diagnosis and staging

Current status and future prospects

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

No simple screening test for prostatic cancer (CaP) is yet available. Likewise, in most cases, accurate staging requires surgical exploration to determine nodal metastases although there are no data to support the concept that pelvic lymphadenectomy cures nodal disease. Future developments which may significantly alter our ability to diagnose and stage CaP include hybridoma techniques, nuclear magnetic resonance and positron imaging tomography.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alhonen-Hongisto L, Seppanen P, Janne J (1980) Intracellular putrescine and spermidine deprivation induces increased uptake of the natural polyamines and methylglyoxal bis (guanylhydrazone). Biochem J 192:941

    Google Scholar 

  2. Andersson L, Jonsson G, Brunk U (1967) Puncture biopsy of the prostate in the diagnosis of prostatic cancer. Scand J Urol Nephrol 1:227

    Google Scholar 

  3. Barzell W, Bean MA, Hilaris BS, Whitmore WF Jr (1977) Prostatic adenocarcinoma: relationship of grade and local extent to pattern of metastases. J Urol 118:278

    Google Scholar 

  4. Belitsky P, Elhilali MM, Oliver JA, Mackinnon KJ (1970) Serum lactate dehydrogenase isoenzyme chenges in carcinoma of the prostate. J Urol 103:770

    Google Scholar 

  5. Belville WD, Mahan DE, Sepulveda RA, Bruce AW, Miller CF (1981) Bone marrow acid phosphatase by radioimmunoassay: three years of experience. J Urol 125:809

    Google Scholar 

  6. Bishop MC, Fellows GJ (1977) Urine hydroxyproline excretion — a marker of bone metastases in prostatic carcinoma. Br J Urol 49:711

    Google Scholar 

  7. Catalona WJ, Stein A, Fair WR (1982) Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade and predicting pelvic lymph node metastases. J Urol 127:919

    Google Scholar 

  8. Cline WA Jr, Kramer SA, Farnham R, Cox EB, Glenn JF, Hinshaw W, Paulson DF (1981) Impact of pelvic lymphadectomy in patients with prostatic adenocarcinoma. Urology 17:129

    Google Scholar 

  9. Donohue RE, Fauver HE, Whitesel JA, Pfister RR (1979) Staging prostatic cancer: a different distribution. J Urol 122:327

    Google Scholar 

  10. Esposti PL (1971) Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. Scand J Urol Nephrol 5:199

    Google Scholar 

  11. Fair WF, Wehner N, Brorsson U (1975) Urinary polyamine levels in the diagnosis of carcinoma of the prostate. J Urol 114:88

    Google Scholar 

  12. Fair WR, Heston WDW, Kadmon D, Crane DB, Catalona WJ, Ladenson JH, McDonald JM, Noll BW, Harvey G (1982) Prostatic cancer, acid phosphatase, creatinine kinase-BB and race: a prospective study. J Urol 128:735

    Google Scholar 

  13. Fleischmann J, Catalona WJ, Fair WR, Heston WDW (1982) Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for early prostate cancer. J Urol (in press)

  14. Foti AG, Cooper JF, Herschman H, Malvaez RR (1977) Detection of prostatic cancer by solid phase radioimmunoassay of serum prostatic acid phosphatase. N Engl J Med 297:1357

    Google Scholar 

  15. Frankel AE, Rouse RV, Wang MC, et al (1982) Monoclonal antibodies to a human prostate antigen. Cancer Res 42:3714

    Google Scholar 

  16. Franzen S, Giertz G, Zajicek J (1960) Cytological diagnosis of prostatic tumor by transrectal aspiration biopsy: a preliminary report. Br J Urol 21:193

    Google Scholar 

  17. Freiha F, Bagshaw MA (1982) Personal communication

  18. Golimbu M, Morales P, Al-Askari S, Shulman Y (1981) CAT scanning and staging of prostatic cancer. Urology 23:305

    Google Scholar 

  19. Grayhack JT, Lee C (1981) Evaluation of prostatic fluid in prostatic pathology. In: Murphy GP, Sandberg AA, Karr JP (eds) The prostatic cell: structure and function. Liss, New York, p 231

    Google Scholar 

  20. Guinan P, Bush I, Ray V, Vieth R, Rao R, Bhatti R (1980) The accuracy of the rectal examination in the diagnosis of prostate carcinoma. N Engl J Med 303:499

    Google Scholar 

  21. Heby O (1981) Role of polyamines in control of cell proliferation and differentiation. Differentiation 19:1

    Google Scholar 

  22. Hilaris BS, Whitmore WF Jr, Batata MA, Grabstald H (1974) Radiation therapy and pelvic node dissection in the management of cancer of the prostate. Am J Roentgenol 121:832

    Google Scholar 

  23. Hoekstra WJ, Schroeder FH (1981) The role of lymph angiography in the staging of prostatic cancer. Prostate 2:433

    Google Scholar 

  24. Hoplins SC, Soloway MS, Palmier GM (1982) Serial spot hydroxyprolne/creatinine ratios in metastatic prostate cancer. Surg Forum 33:649

    Google Scholar 

  25. Kadmon D, Heston WDW, Fair WR (1982) Alpha-difluoromethylornithine can greatly enhance putrescine uptake by a prostatic tumor. Surg Forum 33:634

    Google Scholar 

  26. Kadmon D, Heston WDW, Lazan D, Fair WR (1982) Difluoromethylornithine enhancement of putrescine uptake into the prostate: concise communication. J Nucl Med 23:998

    Google Scholar 

  27. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495

    Google Scholar 

  28. Kramer SA, Cline WA Jr, Farnham R, Carson CC, Cox EB, Hinshaw W, Paulson DF (1981) Prognosis of patients with stage D1 prostatic adenocarcinoma. J Urol 125:817

    Google Scholar 

  29. National prostatic cancer project (1982) A working report for FY 1982 and future projections. Prostatic Cancer Newslett 10:4

    Google Scholar 

  30. Oldendorf WH (1982) NMR imaging: its potential clinical impact. Hosp Pract 114:September

  31. Olsson CA, Tannenbaum M, Babayan R, O'Brien M, deVere White R (1982) Prediction of pelvic lymph node metastases in adenocarcinoma of the prostate. American Urologic Association Annual Meeting, Kansas City, Missouri, May 1982 (abstr no 237)

  32. Paulson DF, Uro-Oncology Research Group (1979) The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma. J Urol 121:300

    Google Scholar 

  33. Paulson DF (1980) The prognostic role of lymphadenectomy in adenocarcinoma of the prostate. Urol Clin North Am 7:615–622

    Google Scholar 

  34. Paulson DF (1982) Personal communication

  35. Phelps ME, Kuhl DE, Mazziotta JC (1981) Metabolic mapping of the brain's response to visual stimulation: studies in humans. Science 211:445

    Google Scholar 

  36. Powels TJ, Leese CL, Bondy PK (1975) Hydroxyproline excretion in patients with breast cancer. Br Med J 2:164

    Google Scholar 

  37. Prockop DJ, Kivirikko KJ (1967) Relationship of hydroxyproline in urine to collagen metabolism. Ann Intern Med 66:1243

    Google Scholar 

  38. Resnick MI, Willard JW, Boyce WH (1980) Transrectal ultrasonography in the evaluation of patients with prostatic carcinoma. J Urol 124:482

    Google Scholar 

  39. Russell DH, Levy CC (1971) Polyamine accumulation and biosynthesis in a mouse L 1210 leukemia. Cancer Res 31:248

    Google Scholar 

  40. Schaffer DL, Pendegrass HP (1976) Comparison of enzyme, clinical, radiographic and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 121:431

    Google Scholar 

  41. Silverman LM, Dermer GB, Zseig MH, et al (1979) Creatinine kinase BB: a new tumor associated marker. Clin Chem 25:1432

    Google Scholar 

  42. Tabor H, Tabor CW (1964) Spermidine, spermine and related amines. Pharmacol Rev 16:245

    Google Scholar 

  43. Ter-Pogossian M, Phelps ME, Hoffman EJ, et al (1975) A positron emission transaxial tomography for nuclear imaging (PETT). Radiology 114:89

    Google Scholar 

  44. Wang MC, Papsidero LD, Kuriyama M, Valenzuela LA, Murphy GP, Chu TM (1981) Prostate antigen: a new potential marker for prostatic cancer. Prostate 2:89

    Google Scholar 

  45. Watanabe H, Igari D, Tanahashi Y, et al (1975) Transrectal ultrasonotomography of the prostate. J Urol 114:734

    Google Scholar 

  46. Whitesel JA, Donohue RE, Mani JH, Fauver HE, Augspurger RR, Biber RJ, Scanavino DJ, Pfister RR (1982) Acid phosphatase -its influence on pelvic lymph node dissection. American Urologic Association annual Meeting, Kansas City, Missouri, May 1982 (abstr no 236)

  47. Whitmore WF Jr, Batata MA, Hilaris BS (1979) Prostatic irridation: iodine-125 implantation. In: Johnson DE, Samuels ML (eds) Cancer of the genitourinary tract. Raven Press, New York, p 195

    Google Scholar 

  48. Willems JS, Lowhagen T (1981) Transrectal fine-needle aspiration biopsy for cytologic diagnosis and grading of prostatic carcinoma. Prostate 2:381

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Washington University School of Medicine, 4960 Audubon Avenue, 63110, St. Louis, Missouri, USA

    W. R. Fair & D. Kadmon

Authors
  1. W. R. Fair
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Kadmon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fair, W.R., Kadmon, D. Carcinoma of the prostate: Diagnosis and staging. World J Urol 1, 3–11 (1983). https://doi.org/10.1007/BF00326855

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00326855

Keywords

Search

Navigation